Ep. 2: Unifying the Old and New – How “Virtual” Components are Changing Clinical Trials

In this episode, Host Kathy Vandebelt discusses decentralized trials with Dylan Rosser, Executive Director of Global Development Operations at Amgen. Dylan brings to light the various virtual components that are used and can be stitched together in a trial. He also talks about the importance of the patient in clinical research, and highlights the benefits decentralized trials can bring to them.